News & Articles

Sativex® for the Treatment of AgitatioN in Dementia (STAND trial)

Discover how the use of high-throughput pipetting tools can facilitate this cutting-edge gene-editing tool

Easily prepare accurate working standards with the new certified reference material from Restek

Surgical transfer of nerves enables a change in muscle identity to improve prosthesis connection and movement

Discover a solution that can help you ensure your data is accurate and consistent

Multi-centre study published in New England Journal of Medicine suggests CAR-T therapy could improve outcome in B-cell lymphoma patients

Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition

Advanced analytical quality control and multi-sample visualization included in LIMS system upgrade

Excellent safety profile reported so far, results expected summer 2019

We interview a scientist whose team designed AAV vectors used in a successful gene therapy clinical trial, and highlight the key technologies that supported his efforts

Study results recently published in the international journal of Caner could improve global public health by enabling more precise and specific screening for HPV

Collaboration unites a worldwide leader in the clinical diagnostics industry with one of the nation’s top research and healthcare institutions to address today’s healthcare challenges

Largest African genetics resource presented at ASHG 2018 annual meeting

HeartMate 3 offers significant advancements for patients not eligible for a heart transplant

Clinical study results suggest individuals with type I or II diabetes may achieve improved glycaemic control with Tresiba

This intelligent surgical device is a cornerstone in the surgical removal of cancers

The test supports international guidelines for treating antibiotic resistant STI

The National Center for Tumor Diseases and Protagen AG collaborate to improve information integration

Machine-learning system determines the fewest, smallest doses that could still shrink brain tumors

Novel drug, aducanumab, successfully attacks and clears amyloid β protein deposits